Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Bristol-Myers Squibb (NY: BMY)
57.87 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 6:19 AM EDT, Apr 7, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 199
Open 57.87
Bid (Size) 58.40 (1)
Ask (Size) 59.30 (1)
Prev. Close 57.87
Today's Range 57.87 - 57.87
52wk Range 42.48 - 68.34
Shares Outstanding 1,634,538,458
Dividend Yield 2.76%
Performance
YTD
-8.64%
-8.64%
1 Month
+3.06%
+3.06%
3 Month
-8.11%
-8.11%
6 Month
+13.74%
+13.74%
1 Year
+23.68%
+23.68%
Top News
More News
U.S. Food and Drug Administration (FDA) Approves Reblozyl® (luspatercept-aamt), the First and Only Erythroid Maturation Agent, to Treat Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS)
FDA Approves Reblozyl®, the First and Only Erythroid Maturation Agent, to Treat Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Read More
from Business Wire News Releases
Over 35 Companies In Race To Develop Vaccine For COVID-19 Health Crises
category Featured News
from FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
More News
Read More
Over 35 Companies in Race to Develop Vaccine for COVID-19 Health Crises
from PR Newswire
Jerome Zeldis, M.D., Ph.D, Appointed as Executive Chair of ViralClear Pharmaceuticals, Inc.
category BSGM News
from FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Jerome Zeldis, M.D., Ph.D, Appointed as Executive Chair of ViralClear Pharmaceuticals, Inc.
from GlobeNewswire News Releases
Former Celgene Drug Earns a Key Approval for Bristol Myers Squibb
category Market News , BMY
from Motley Fool
Thinking about trading options or stock in Bristol-Myers Squibb, Chevron Corp, Docusign, Intel Corp, or Tesla?
from PR Newswire
Bristol Myers Squibb and bluebird bio Announce Submission of Biologics License Application (BLA) for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, bb2121) to FDA
from Business Wire News Releases
Should You Buy Illumina Stock During the Coronavirus Bear Market?
category ILMN , PACB , LLY , and 3 more.
from Motley Fool
OEF, COST, ABT, BMY: ETF Inflow Alert
category ETFs
from ETF Channel
Coronavirus-Led Volatility Rises: 5 High Earnings Yield Picks
category Stocks / Equities
from Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.